Presenter: Jason Moore, PhD, FACMI
Presenter: Saja Al-Alawneh, MS and Sam Rosko, BS
Presenter: Chandra Rathnam, BS; Xueer Chen, MS; and Luca Calzoni, MD
Presenter: Sanghoon Lee, MS; Timothy Mtonga, BS
Presenter: No Lecture
Presenter: Richard Boyce, PhD

The long-term goal of the proposed work is to develop an effective informatics intervention that prevents harm to nursing home (NH) residents from potential drug-drug interactions (PDDIs) while avoiding known issues with interaction alerting such as alert fatigue. In this talk I will discuss progress toward that goal that examines the feasibility and potential clinical usefulness of actively monitoring patients exposed to psychotropic drugs.

Presenter: John Paisley, PhD

Recent developments in scalable Bayesian inference have enabled fast learning of complex probabilistic models using massive data sets. We will discuss these developments in the context of topic models of discrete grouped data, focusing on text. We will review our recent collaborations on scalable model learning using stochastic variational inference, and discuss new applications to structured hierarchical topic models.

Presenter: No Lecture
Presenter: Andy King, MS

Eye-tracking is a valuable research tool that is used in laboratory and limited field environments. We take steps toward developing methods that enable widespread adoption of eye-tracking and its real-time application in clinical decision support. Eye-tracking will enhance awareness and enable intelligent views, more precise alerts, and other forms of decision support in the Electronic Medical Record (EMR). We evaluated a low-cost eye-tracking device and found the device’s accuracy to be non-inferior to a more expensive device.

Presenter: Nancy Lan Guo, PhD

The FDA and EPA have identified pharmacogenomics and toxicogenomics as key opportunities for personalized medicine and environmental risk assessment. The first decade in the 21st century has witnessed breakthroughs in molecular diagnosis and prognosis in cancer treatment.  It has now become increasingly important to transform environmental health protection by using high throughput assays to identify genomic biomarkers for personalized risk assessment. This talk will introduce two projects in Dr.